189 related articles for article (PubMed ID: 34206297)
1. Targeting Telomere Biology in Acute Lymphoblastic Leukemia.
Karow A; Haubitz M; Oppliger Leibundgut E; Helsen I; Preising N; Steiner D; Dantonello TM; Ammann RA; Roessler J; Kartal-Kaess M; Röth A; Baerlocher GM
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206297
[TBL] [Abstract][Full Text] [Related]
2. Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
Frink RE; Peyton M; Schiller JH; Gazdar AF; Shay JW; Minna JD
Oncotarget; 2016 May; 7(22):31639-51. PubMed ID: 27192120
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia.
Kubuki Y; Suzuki M; Sasaki H; Toyama T; Yamashita K; Maeda K; Ido A; Matsuoka H; Okayama A; Nakanishi T; Tsubouchi H
Leuk Lymphoma; 2005 Mar; 46(3):393-9. PubMed ID: 15621829
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
Engelhardt M; Ozkaynak MF; Drullinsky P; Sandoval C; Tugal O; Jayabose S; Moore MA
Leukemia; 1998 Jan; 12(1):13-24. PubMed ID: 9436916
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome.
Park HS; Choi J; See CJ; Kim JA; Park SN; Im K; Kim SM; Lee DS; Hwang SM
Ann Lab Med; 2017 May; 37(3):195-203. PubMed ID: 28224765
[TBL] [Abstract][Full Text] [Related]
6. Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias.
Capraro V; Zane L; Poncet D; Perol D; Galia P; Preudhomme C; Bonnefoy-Berard N; Gilson E; Thomas X; El-Hamri M; Chelghoun Y; Michallet M; Wattel E; Mortreux F; Sibon D
Exp Hematol; 2011 Feb; 39(2):195-202.e2. PubMed ID: 21056083
[TBL] [Abstract][Full Text] [Related]
7. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
8. Effect of telomerase inhibition on preclinical models of malignant rhabdoid tumor.
Hu Y; Bobb D; Lu Y; He J; Dome JS
Cancer Genet; 2014 Sep; 207(9):403-11. PubMed ID: 25441685
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
10. The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia.
da Mota THA; Camargo R; Biojone ER; Guimarães AFR; Pittella-Silva F; de Oliveira DM
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980962
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity and telomere length in acute leukemia: correlations with disease progression, subtypes and overall survival.
Wang Y; Fang M; Sun X; Sun J
Int J Lab Hematol; 2010 Apr; 32(2):230-8. PubMed ID: 19614710
[TBL] [Abstract][Full Text] [Related]
12. Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.
Barszczyk M; Buczkowicz P; Castelo-Branco P; Mack SC; Ramaswamy V; Mangerel J; Agnihotri S; Remke M; Golbourn B; Pajovic S; Elizabeth C; Yu M; Luu B; Morrison A; Adamski J; Nethery-Brokx K; Li XN; Van Meter T; Dirks PB; Rutka JT; Taylor MD; Tabori U; Hawkins C
Acta Neuropathol; 2014 Dec; 128(6):863-77. PubMed ID: 25120190
[TBL] [Abstract][Full Text] [Related]
13. The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth.
Marian CO; Cho SK; McEllin BM; Maher EA; Hatanpaa KJ; Madden CJ; Mickey BE; Wright WE; Shay JW; Bachoo RM
Clin Cancer Res; 2010 Jan; 16(1):154-63. PubMed ID: 20048334
[TBL] [Abstract][Full Text] [Related]
14. Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions.
Vasko T; Kaifie A; Stope MB; Kraus T; Ziegler P
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29143804
[TBL] [Abstract][Full Text] [Related]
15. The association of telomere length and telomerase activity with adverse outcomes in older patients with non-ST-elevation acute coronary syndrome.
Chan D; Martin-Ruiz C; Saretzki G; Neely D; Qiu W; Kunadian V
PLoS One; 2020; 15(1):e0227616. PubMed ID: 31923255
[TBL] [Abstract][Full Text] [Related]
16. Relationship between Initial Telomere Length, Initial Telomerase Activity, Age, and Replicative Capacity of Nucleus Pulposus Chondrocytes in Human Intervertebral Discs: What Is a Predictor of Replicative Potential?
Lee JS; Jeong SW; Cho SW; Juhn JP; Kim KW
PLoS One; 2015; 10(12):e0144177. PubMed ID: 26633809
[TBL] [Abstract][Full Text] [Related]
17. High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.
Oh BK; Kim H; Park YN; Yoo JE; Choi J; Kim KS; Lee JJ; Park C
Lab Invest; 2008 Feb; 88(2):144-52. PubMed ID: 18158557
[TBL] [Abstract][Full Text] [Related]
18. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival.
Wu KD; Orme LM; Shaughnessy J; Jacobson J; Barlogie B; Moore MA
Blood; 2003 Jun; 101(12):4982-9. PubMed ID: 12609839
[TBL] [Abstract][Full Text] [Related]
19. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
[TBL] [Abstract][Full Text] [Related]
20. A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer.
Chiappori AA; Kolevska T; Spigel DR; Hager S; Rarick M; Gadgeel S; Blais N; Von Pawel J; Hart L; Reck M; Bassett E; Burington B; Schiller JH
Ann Oncol; 2015 Feb; 26(2):354-62. PubMed ID: 25467017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
